炭疽病治療の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Anthrax Treatment Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: PIPELINE ANALYSIS
• Pipeline analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Vaccine – Market size and forecast 2018-2023
• Drug therapy – Market size and forecast 2018-2023
• Market opportunity by product
PART 08: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Increase in research funding
• Increase in development of new therapies
• Development of vaccines against bioterrorism-associated anthrax
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer
• Elusys Therapeutics
• Emergent BioSolutions
PART 16: APPENDIX
• Research methodology
• List of abbreviations

Exhibit 01: Global infectious disease treatment market
Exhibit 02: Segments of global infectious disease treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline drugs in clinical trials
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Market condition – Five forces 2018
Exhibit 16: Product – Market share 2018-2023 (%)
Exhibit 17: Comparison by product
Exhibit 18: Vaccine – Market size and forecast 2018-2023 ($ millions)
Exhibit 19: Vaccine – Year-over-year growth 2019-2023 (%)
Exhibit 20: Drug therapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Drug therapy – Year-over-year growth 2019-2023 (%)
Exhibit 22: Market opportunity by product
Exhibit 23: Customer landscape
Exhibit 24: Market share by geography 2018-2023 (%)
Exhibit 25: Geographic comparison
Exhibit 26: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 28: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 30: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 32: Key leading countries
Exhibit 33: Market opportunity
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Vendor landscape
Exhibit 36: Landscape disruption
Exhibit 37: Vendors covered
Exhibit 38: Vendor classification
Exhibit 39: Market positioning of vendors
Exhibit 40: Bayer – Vendor overview
Exhibit 41: Bayer – Business segments
Exhibit 42: Bayer – Organizational developments
Exhibit 43: Bayer – Geographic focus
Exhibit 44: Bayer – Segment focus
Exhibit 45: Bayer – Key offerings
Exhibit 46: Elusys Therapeutics – Vendor overview
Exhibit 47: Elusys Therapeutics – Organizational developments
Exhibit 48: Elusys Therapeutics – Key offerings
Exhibit 49: Emergent BioSolutions – Vendor overview
Exhibit 50: Emergent BioSolutions – Business segments
Exhibit 51: Emergent BioSolutions – Organizational developments
Exhibit 52: Emergent BioSolutions – Key offerings


【レポート販売概要】

■ タイトル:炭疽病治療の世界市場2019-2023
■ 英文:Global Anthrax Treatment Market 2019-2023
■ 発行日:2018年11月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR30185
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。